1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell CarcinomaConcurrent Chemoradiotherapy; Immunonutrition; Locally Advanced Esophageal Squamous Cell Carcinoma; Radiotherapy; SintilimabRecruitingPhase 22026-10-07NCT06342167